Table 1.
Obese Subjects (n = 40) | Controls (n = 20) | P Value | |
---|---|---|---|
Sex (male %) | 32 (80) | 15 (75) | NS |
Age (years) | 54 ± 10 | 50 ± 9 | NS |
BMI (Kg/m2) | 29.4 ± 3.0 | 21.5 ± 2.0 | <0.01 |
Hypertension (%) | 13 (32.5) | 5 (25) | NS |
Diabetes mellitus (%) | 5 (12.5) | 2 (10) | NS |
SBP (mmHg) | 133 ± 18 | 127 ± 16 | NS |
DBP (mmHg) | 80 ± 10 | 83 ± 11 | NS |
Fasting glucose (mmol/L) | 5.87 ± 1.84 | 5.31 ± 1.90 | NS |
Total cholesterol (mmol/L) | 4.9 ± 0.9 | 5.0 ± 0.5 | NS |
LDL cholesterol (mmol/L) | 2.9 ± 0.8 | 3.0 ± 0.6 | NS |
HDL cholesterol (mmol/L) | 1.2 ± 0.3 | 1.5 ± 0.4 | NS |
Triglycerides (mmol/L) | 1.8 ± 0.8 | 1.4 ± 0.7 | NS |
LAD (mm) | 37.6 ± 7.3 | 29.6 ± 4.8 | <0.01 |
LVEDD (mm) | 45.5 ± 3.6 | 44.1 ± 3.2 | NS |
IVST (mm) | 9.8 ± 2.7 | 8.0 ± 1.9 | <0.05 |
LVEF (%) | 58.8 ± 6.9 | 65.2 ± 6.5 | NS |
Medications | |||
Statin (%) | 11 (27.5) | 6 (30) | NS |
ACEIs or ARBs (%) | 7 (17.5) | 3 (15) | NS |
CCBs (%) | 8 (20) | 3 (15) | NS |
Diuretics (%) | 3 (7.5) | 1 (5) | NS |
Bold indicates a significant difference between the two groups. BMI = body mass index; NS = not significant; SBP = Systolic blood pressure; DBP = diastolic blood pressure; LDL‐c, low‐density lipoprotein; HDL‐c, high‐density lipoprotein; LAD = left atrial diameter; LVEDD = left ventricular end‐diastolic diameter; LVEF = left ventricular ejection fraction; IVST = interventricular septum thickness ACEIs = angiotensin‐converting enzyme inhibitors; ARBs = angiotensin receptor blockers; CCBs = calcium channel blockers.